Marcel Brown | Medicine and Dentistry | Research Excellence Award

Dr. Marcel Brown | Medicine and Dentistry | Research Excellence Award

Atrium Health Wake Forest Baptist | United States

Dr. Marcel Brown is a clinician–scientist whose research portfolio integrates orthopaedic surgery, regenerative medicine, translational molecular science, and cardiovascular physiology, with a strong emphasis on clinically impactful, mechanism-driven investigation. His scholarly output comprises 7 peer-reviewed documents, which have collectively received 145 citations, reflecting an h-index of 3, indicative of consistent citation impact across his publications. His research experience spans advanced orthopaedic outcomes research, musculoskeletal infection prevention, stem cell and acellular biologic therapies for osteoarthritis and post-traumatic osteoarthritis, and translational studies evaluating tissue regeneration, inflammation, and functional recovery using in vitro, in vivo, and ex vivo models. Complementing this work, he has contributed substantially to cardiovascular and exercise physiology research, including investigations into exercise-induced cardiac remodeling, pulmonary vascular disease, metabolic and hormonal responses to physical stress, and molecular mechanisms underlying maladaptive vascular fibrosis. His interdisciplinary collaborations have resulted in publications across high-impact journals in orthopaedics, translational medicine, cardiovascular science, and cell biology, including original research articles, systematic analyses, and clinically relevant case reports. Collectively, his research demonstrates a sustained commitment to bridging basic science with clinical application, advancing evidence-based surgical practice, regenerative strategies, and cardiometabolic health through rigorously designed translational and outcomes-focused studies.

 

Citation Metrics (Scopus)

150120

90

60

30

0

Citations
145

Documents
7

h-index
3

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Risk factors for failure after lumbar tubular microdecompression without stabilization
– Journal of the American Academy of Orthopaedic Surgeons, 2025

Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Prof. Yunlong Wang | Medicine and Dentistry | Best Researcher Award

Beijing Anzhen Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Yunlong Wang began his illustrious academic journey at the prestigious Peking University Health Science Center, where he earned his Doctor of Cardiology (M.D.). Driven by an unwavering passion for cardiac sciences, he later expanded his expertise internationally through visiting scholar roles at Asklepios St. Georg Hospital, University of Chicago Hospital, and the Hospital of the University of Pennsylvania , specializing in electrophysiology. These experiences provided a robust foundation for his future contributions to cardiac arrhythmia treatment.

Professional Endeavors

Prof. Wang has been a cornerstone of Beijing Anzhen Hospital, Capital Medical University since 2007. As the Chief Physician and Executive Director of the Arrhythmias Ward Three, he oversees the department’s advanced cardiac electrophysiology operations. With unmatched skill, he performs over 1400 tachyarrhythmia radiofrequency ablation procedures annually. In addition to his clinical duties, he is a respected doctoral supervisor, educator for undergraduate medical students, and a key figure in national cardiovascular intervention training programs authorized by China’s National Health Commission.

Contributions and Research Focus

Prof. Wang’s clinical expertise centers on the diagnosis and radiofrequency ablation treatment of complex tachyarrhythmias such as persistent atrial fibrillation, premature ventricular contractions, and ventricular tachycardia. His research portfolio includes pivotal studies in both basic and clinical science. His fundamental research has been supported by the National Natural Science Foundation of China, examining the roles of CRT and the HIF-1α-Nkx2.5 axis in cardiac remodeling and ion channel regulation. His clinical investigations have significantly advanced understanding and treatment of arrhythmias, with more than ten SCI-indexed papers published as lead or corresponding author in the last five years.

Accolades and Recognition

Prof. Wang is a prominent member of several key professional bodies, including the National Committee of the Chinese Society of Biomedical Engineering (Electrocardiogram Technology Branch), and serves on the youth committees of the Heart Rhythm Branch and Beijing Medical Association. His scholarly contributions have been featured in high-impact journals such as Heart Rhythm, Europace, and J Cardiovasc Electrophysiol, affirming his stature in the field of cardiac electrophysiology.

Impact and Influence

Prof. Wang's leadership in arrhythmia treatment has redefined procedural benchmarks across China. By educating the next generation of cardiologists and shaping national training protocols, his influence permeates both clinical and academic spheres. His pioneering research in radiofrequency ablation and cardiac electrophysiology continues to inform best practices globally.

Legacy and Future Contributions

Prof. Wang’s legacy is built on a blend of surgical excellence, scientific inquiry, and educational mentorship. As cardiac electrophysiology continues to evolve, his ongoing research into molecular pathways and ablation techniques is poised to unlock new treatment paradigms. With a steadfast commitment to innovation and clinical precision, he remains a vital contributor to the future of cardiovascular medicine in China and beyond.

 

Publications


The mC2HEST Score for Incident Atrial Fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis)

  • Authors: Yanguang Li, Qiaoyuan Li, Lili Wang, Tao Zhang, Hai Gao, Daniele Pastori, Zhuo Liang, Gregory Y.H. Lip, Yunlong Wang

  • Journal: JACC: Advances

  • Year: 2025


Left atrial size and echocardiographic diastolic parameters as predictors of incident atrial fibrillation in older hospitalized patients

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Aging Clinical and Experimental Research

  • Year: 2025


Atrial fibrillation phenotypes identified through cluster analysis in the CABANA study

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: International Journal of Cardiology

  • Year: 2025


Prompt Identification of the Location of Gap Conduction in the Mitral Isthmus Following Vein of Marshall Ethanol Infusion and Endocardial Ablation

  • Authors: [Not fully listed; assumed to include Yunlong Wang as part of the team]

  • Journal: Circulation: Arrhythmia and Electrophysiology

  • Year: 2025


Downregulation of SENP1 impairs nuclear condensation of MEF2C and deteriorates ischemic cardiomyopathy

  • Authors: Ying Xie, Qiaoyuan Li, Xiyun Bian, Yan Yin, Zhuo Liang, Xu Liu, Tao Zhang, Xiaozhi Liu, Xin Quan, Yunlong Wang

  • Journal: Clinical and Translational Medicine (Wiley)

  • Year: 2025


 

Armin Arshi | Medicine and Dentistry | Best Researcher Award

Dr. Armin Arshi | Medicine and Dentistry | Best Researcher Award

NYU Langone Health | United States

Author Profile

Scopus

Google Scholar

🌱 Early Academic Pursuits

Dr. Armin Arshi began his academic journey with distinction, graduating Summa Cum Laude with a Bachelor of Science in Bioengineering from UCLA in 2012. He complemented his technical depth with a specialization in Materials Science and Engineering. Driven by a passion for medicine and innovation, he pursued his Doctor of Medicine at the David Geffen School of Medicine at UCLA, earning membership in the prestigious Alpha Omega Alpha (AΩA) Honor Medical Society and receiving multiple academic awards for excellence in research and leadership.

🏥 Professional Endeavors

Following medical school, Dr. Arshi underwent rigorous Orthopaedic Surgery residency training at UCLA, where he served as Administrative Chief Resident. He then pursued a Fellowship in Adult Reconstruction at the Rothman Orthopaedic Institute, a globally respected hub for joint replacement. His clinical career has included prominent roles as Attending Orthopaedic Surgeon at NYU Langone Health and currently at Beach Orthopaedic Specialty Institute and UCI Health in California. As an Assistant Professor at NYU Grossman School of Medicine, he has shaped orthopedic education and research.

🔬 Contributions and Research Focus

Dr. Arshi’s research spans joint arthroplasty, surgical outcomes, infection control, and implant biomechanics. He has authored numerous peer-reviewed publications in elite journals like The Journal of Arthroplasty and Arthroplasty Today, addressing topics from patient follow-up to periprosthetic joint infection and predictive modeling. His innovative studies have earned recognition at prestigious meetings including AAOS, NASS, and Western Orthopaedic Association. He has also contributed to surgical literature through influential book chapters and national guidelines.

🏅 Accolades and Recognition

Dr. Arshi’s excellence has been honored with the Stafford L. Warren Medal (UCLA’s highest medical school award), numerous resident research awards, and national research prizes, including the NIH DEBUT Competition and Howard Hughes Fellowships. His leadership in orthopedics is further affirmed through roles on editorial boards of major journals and review panels, demonstrating both scientific rigor and peer respect.

🌍 Impact and Influence

With a keen focus on evidence-based medicine, Dr. Arshi’s work has impacted clinical decision-making in joint replacement, particularly in VTE prophylaxis, return-to-sport protocols, and implant longevity. His efforts to understand disparities in patient outcomes and enhance surgical education have made significant strides in advancing personalized orthopedic care. He is a thought leader committed to improving both technical standards and patient experiences.

🔮 Legacy and Future Contributions

Poised at the intersection of clinical mastery and academic excellence, Dr. Arshi is a rising force in orthopaedics. His commitment to innovation, mentorship, and multidisciplinary collaboration positions him to be a lasting influence in orthopedic surgery and medical education. As he continues to lead in surgery, research, and institutional quality initiatives, his legacy will shape the next generation of joint reconstruction techniques and orthopedic leaders.

Publications


📄 Patient characteristics associated with loss to follow-up after total joint arthroplasty
Authors: Ruff G, Sarfraz A, Lawrence KW, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Risk of early manipulation in cemented versus cementless total knee arthroplasty: analysis of the American Joint Replacement Registry
Authors: Schaffler B, Zaniletti I, Arshi A, De M, Schwarzkopf R, Rozell JC
Journal: Journal of Arthroplasty
Year: 2025


📄 Why do total joint arthroplasties get canceled on the day of surgery?
Authors: Sandoval CG, Katzman JL, Connolly P, Grossman EL, Arshi A, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2025


📄 Total joint arthroplasty patients from distressed communities return to sports and physical activities at lower rates
Authors: Cozzarelli NF, Khan IA, Arshi A, Sherman MB, Fillingham YA
Journal: Journal of Arthroplasty
Year: 2025


📄 Aseptic tibial loosening is associated with thickness of the cement: a radiographic case-control study
Authors: Schaffler B, Robin JX, Katzman J, Arshi A, Rozell JC, Schwarzkopf R
Journal: Journal of Arthroplasty
Year: 2024


Kalei Hering | Medicine and Dentistry | Best Researcher Award

Dr. Kalei Hering | Medicine and Dentistry | Best Researcher Award

Harvard Medical School | United States

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Kalei Hering’s academic journey began at the United States Military Academy at West Point, where she majored in Life Sciences with honors, following a pre-medical and nuclear engineering track. As a Barry Goldwater Scholar and Rhodes Scholar Finalist, her undergraduate years were marked by distinction and ambition. She then advanced to Harvard Medical School, where she pursued her M.D. with exceptional performance, scoring a 265 on the USMLE Step 2 CK and actively engaging in research and leadership.

🩺 Professional Endeavors

Currently a Resident Physician in Diagnostic Radiology at Walter Reed National Military Medical Center (expected 2030), Dr. Hering is integrating rigorous clinical training with a robust military medical background. She has held numerous leadership positions—from Platoon Leader to President of Harvard’s Interventional Radiology Interest Group—reflecting a rare blend of military discipline and medical acumen. Her clinical and surgical experiences at institutions like Walter Reed, MGH, and BIDMC have laid a strong foundation for a future in academic and interventional radiology.

🔬 Contributions and Research Focus

Dr. Hering’s research spans vascular and interventional radiology, pulmonary arteriovenous malformations, trauma imaging, and military health, with over 20 peer-reviewed publications. She has contributed to top-tier journals including CHEST, Spine Journal, Journal of Vascular and Interventional Radiology, and Military Medicine. As an editor for the MGH “White Book”, she has also shaped essential medical manuals for house staff. Her passion for research was recognized early through internships and fellowships, including work on Lyme disease and steroid hormone physiology.

🏅 Accolades and Recognition

A decorated scholar and athlete, Dr. Hering has earned numerous honors including:
🏆 1897 Fellowship Awardee (Top national Phi Kappa Phi applicant)
🥇 Trainee Case Competition Winner, New England Society of Interventional Radiology
🏃‍♀️ Champion in multiple marathons and ultramarathons including the Candlelight 12-Hour and Spartan Race
🎖️ Excellence in Life Science Award, Brigadier General Ramsden Award, and LTC Boyd Harris Leadership Award at West Point
📚 Recognized by the West Point Superintendent for academic, military, and physical excellence

🌍 Impact and Influence

Dr. Hering is a changemaker in both academic medicine and military health systems. Her efforts to increase access and mentorship—such as developing shadowing programs, founding wellness initiatives, and mentoring underrepresented pre-med students—demonstrate her commitment to building inclusive, high-impact medical communities. Her involvement in the Society of Interventional Radiology, Excelsior Surgical Society, and Empower Conference reflects a strategic vision for the future of healthcare delivery, particularly in military and interventional contexts.

🔮 Legacy and Future Contributions

With a rare combination of military leadership, scientific rigor, and clinical excellence, Dr. Kalei Hering is poised to leave a lasting mark on the fields of interventional radiology, medical education, and military medicine. Her pursuit of innovative techniques, policy development, and mentorship ensures that her influence will be deeply felt across clinical, academic, and operational environments for years to come. As she advances through her residency and beyond, Dr. Hering stands as a beacon of resilience, intellect, and service in modern medicine.

Publications


📄 Post-Treatment Monitoring of Pulmonary Arteriovenous Malformations: Challenges and Approaches

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: CHEST

  • Year: 2025


📄 Embolization of a Bleeding Duodenal Arteriovenous Malformation with a Conformable Embolic Material (Obsidio): Case Report

  • Authors: Kalei Hering, Patrick Sutphin, Sanjeeva Kalva

  • Journal: Journal of Clinical Interventional Radiology ISVIR

  • Year: 2025


📄 Long-Term Quality of Life and Functional Outcomes After Management of Spinal Epidural Abscess

  • Authors:  Kalei Hering, Grace X. Xiong, Andrew Nguyen, Andrew J. Schoenfeld

  • Journal:  The Spine Journal

  • Year: 2024


📄 Health-Care Utilization and Expenditures Associated with Long-Term Treatment After Combat and Non-Combat-Related Orthopaedic Trauma

  • Authors: Kalei Hering, Miles W.A. Fisher, Michael K. Dalton, Andrew K. Simpson, Jamie Ye, Nishant Suneja, Zara Cooper, Tracey P. Koehlmoos, Andrew J. Schoenfeld

  • Journal: Journal of Bone and Joint Surgery

  • Year: 2022


 

Jeong A Kim | Medicine and Dentistry | Best Researcher Award

Prof. Jeong A Kim | Medicine and Dentistry | Best Researcher Award

St. Vincent Hospital, The Catholic University of Korea | South Korea

Author Profile

Scopus

Early Academic Pursuits ✨

Prof. Jeong A Kim embarked on an illustrious academic journey in the field of medicine, laying a solid foundation at the Catholic University Medical College. She completed her premedical course in 1986, followed by earning her Doctor of Medicine degree in 1990. Her passion for internal medicine and hematology led her to pursue advanced studies at The Catholic University of Korea, where she obtained a Master’s degree in 1998 and a Ph.D. in 2001. This strong academic background established her as a dedicated scholar committed to the advancement of medical sciences.

Professional Endeavors 🏥

Prof. Kim's professional career began with rigorous postdoctoral training. She completed her internship at St. Mary’s Hospital in 1991, followed by a residency in Internal Medicine at Catholic University Medical College until 1995. She further honed her expertise in hemato-oncology through a fellowship at Samsung Medical Center. Her international exposure expanded when she joined the Department of Microbiology and Immunology at IUPUI, USA, as a postdoctoral researcher. Her academic appointments at The Catholic University of Korea saw a steady rise, from Instructor in 1997 to Assistant Professor in 2001, Associate Professor in 2009, and finally attaining the prestigious title of Professor of Internal Medicine in 2014. In parallel, she has been a dedicated physician at St. Vincent Hospital since 1997 and has been leading the hematology and stem cell transplantation center since 2018.

Contributions and Research Focus 📝

Prof. Kim has made groundbreaking contributions in hematology and oncology, with a primary focus on stem cell transplantation, multiple myeloma, and lymphoma. Her extensive clinical trials and research studies have played a pivotal role in developing new treatment modalities for hematologic malignancies. Her work in targeted therapies, chemotherapy combinations, and immunotherapy has significantly improved patient outcomes and quality of life. She has been involved in more than 60 clinical trials, evaluating novel drug efficacy and safety, including studies on Zoledronic acid for multiple myeloma, targeted treatments like Dasatinib for leukemia, and the role of rituximab in lymphoma. Her research has also delved into prognostic factors, precision medicine, and innovative therapeutic strategies for refractory and relapsed hematologic diseases.

Accolades and Recognition 🏆

Prof. Kim's relentless pursuit of excellence has earned her recognition from esteemed medical institutions and societies. As a member of the Korean Association of Internal Medicine, the Korean Hematology Association, and the American Hematology Association, she has played an instrumental role in shaping global hematologic research. Her contributions have been acknowledged through numerous awards, invitations as a keynote speaker, and influential publications in high-impact medical journals.

Impact and Influence ✨

With a career spanning decades, Prof. Kim has mentored numerous young medical professionals, guiding them in clinical research and evidence-based medical practice. Her work has directly influenced hematologic treatment protocols in Korea and internationally. Her leadership in hematology and stem cell transplantation has set new benchmarks in patient care and innovative treatment approaches.

Legacy and Future Contributions 🌟

Prof. Jeong A Kim's legacy is deeply ingrained in the advancements of hematology and oncology. Her dedication to research, patient care, and education continues to inspire the next generation of medical professionals. Looking ahead, she remains committed to pioneering more targeted therapies, enhancing stem cell transplantation techniques, and improving long-term survival rates for hematologic malignancy patients. With ongoing research and collaborations, she is poised to make even greater strides in the field, leaving an indelible mark on medical science and patient care.

 

Publications


📄 The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma
Authors: H. Cho, J. Kim, Y. Park, Y. Kim, J. Kim, Jeong-ah
Journal: Leukemia Research
Year: 2025


📄 Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma
Authors: N.L. Bartlett, U.H. Hahn, W. Kim, F. Jie, J. Kim, Jeong-ah
Journal: Journal of Clinical Oncology
Year: 2025


📄 Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials
Authors: D. Shin, S. Park, E. Jang, W. Lee, D. Kim
Journal: Leukemia Research
Year: 2024


📄 Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
Authors: H.Y. Yhim, Y. Park, J. Kim, Jeong-ah, D. Yang, J. Kwak
Journal: The Korean Journal of Internal Medicine
Year: 2024


Subhash Chandra Yadav | Health Professions | Best Researcher Award

Prof. Dr. Subhash Chandra Yadav | Health Professions | Best Researcher Award

All India Institute of Medical Sciences, New Delhi | India

Author Profile

Scopus

Google Scholar

Early Academic Pursuits 🎓

Prof. Dr. Subhash Chandra Yadav began his academic journey with an MSc in Biotechnology from Banaras Hindu University (BHU), Varanasi, in 2003. His thirst for knowledge led him to pursue a Ph.D. in Molecular Biology at BHU, which he completed in 2007 under the mentorship of Prof. Jagannadham V. Medicherla. His doctoral research focused on "Milin," a highly stable glycosylated dimeric plant serine protease from Euphorbia milii, examining its structure, function, folding, and crystallographic properties. During his academic development, he also gained international exposure as a research trainee at the Institute of Crystallography, Free University (FU) Berlin, Germany, from September 2005 to April 2006, where he honed his skills in protein structural biology.

Professional Endeavors and Milestones 💼

Dr. Yadav's illustrious career spans prestigious institutions globally:

  • Postdoctoral Fellowships: He worked on molecular biophysics at the Indian Institute of Science (IISc), Bangalore, and at the Graduate School of Medicine, University of Tennessee, USA.
  • Research and Leadership Roles: As a Scientist and In-Charge of Nanobiology and Electron Microscopy Facility at CSIR-IHBT, Palampur, and Fellow at TERI-Deakin Nanobiotechnology Centre, he spearheaded cutting-edge research.
  • Academic Excellence: He has been serving All India Institute of Medical Sciences (AIIMS), New Delhi, since 2015, rising to the role of Additional Professor. He was also a Visiting Professor at Stanford University, USA, in 2019-2020.

Contributions and Research Focus 🔬

Dr. Yadav’s research interests are at the confluence of nanotechnology, molecular biology, and microscopy:

  • Electron Microscopy and Cryo-Electron Tomography: Advancing the understanding of cellular structures at atomic resolution.
  • Nano-enabled Diagnostic Tools: Innovating methods for rapid and accurate disease detection.
  • Targeted Drug Delivery Systems: Developing nanoparticles for precise therapeutics.

His work includes over 6,630 citations, with an h-index of 18, reflecting the impact of his research. His patent portfolio includes innovative detection kits, cancer diagnostics, and nanotechnology-based systems.

Accolades and Recognition 🏆

Dr. Yadav's groundbreaking contributions have earned him numerous accolades:

  • 2024: Fellow of the Electron Microscopy Society of India.
  • 2019: Long-Term Fellowship from the Department of Health Research to work at Stanford University.
  • 2018: Excellence in Microscopy Award by the Electron Microscope Society of India.
  • 2005-2006: Boehringer Ingelheim Fonds Fellowship, Germany.

Impact and Influence 🌍

Dr. Yadav has significantly influenced the fields of nanotechnology and microscopy through his teaching, research, and mentorship. As a member of prestigious societies like the Indian Biophysical Society and a reviewer for leading journals, he has contributed to advancing scientific knowledge. His innovative patents and publications continue to inspire advancements in diagnostics and therapeutics.

Legacy and Future Contributions Highlight 🚀

With a career defined by scientific rigor, international collaboration, and a vision for impactful research, Dr. Yadav stands as a beacon of innovation. His ongoing work in nanotechnology and cryo-electron tomography promises to shape the future of medical diagnostics and targeted therapies, leaving a lasting legacy in science and technology.

 

Publications


📄 Magnetic nanoparticles and quantum dots coupled immuno nano fluorescence assay for visual detection of HPV16-induced cervical cancer cells from cytology/biopsy samples
Authors: Raman, S., Tanwar, P., Meena, J., Bhatla, N., Yadav, S.C.
Journal: Sensing and Bio-Sensing Research
Year: 2024


📄 Genetics of 67 patients of suspected primary ciliary dyskinesia from India
Authors: Jat, K.R., Faruq, M., Jindal, S., Arava, S.K., Kabra, S.K.
Journal: Clinical Genetics
Year: 2024


📄 Quantitative and qualitative analysis of metallic ion release of orthodontic brackets in three different pH conditions - An invitro study
Authors: DA, P., Angel L, S., Chaudhari, P.K., Yadav, S.C., Duggal, R.
Journal: Journal of Oral Biology and Craniofacial Research
Year: 2024


📄 Rab7-dependent regulation of goblet cell protein CLCA1 modulates gastrointestinal homeostasis
Authors: Gaur, P., Rajendran, Y., Srivastava, B., Ahuja, V., Srikanth, C.
Journal: eLife
Year: 2024


📄 Visual, rapid, and cost-effective BK virus detection system for renal transplanted patients using gold nanoparticle coupled loop-mediated isothermal amplification (nanoLAMP)
Authors: Kumar, S., Raman, S., Sesham, K., Mridha, A.R., Yadav, S.C.
Journal: Journal of Virological Methods
Year: 2024


 

Filippo Carannante | Medicine and Dentistry | Best Research Award

Dr. Filippo Carannante | Medicine and Dentistry | Best Research Award 

UOC Chirurgia Colorettale, Fondazione Policlinico Campus Bio-Medico di Roma | Italy 

Author Profile

Scopus

Orcid

🎓 Early Academic Pursuits

Dr. Filippo Carannante's academic journey began at the Bio-Medico Campus University of Rome, where he graduated with a degree in Medicine and Surgery, achieving a perfect score of 110/110 cum laude. He completed a specialized training program in General Surgery Residency at the same institution, culminating in a thesis on the oncological outcomes of rectal cancer patients. He further enhanced his expertise with various fellowships and specialized courses, including a PhD program in Biomedical Sciences and Bioethics focused on osteo-oncological diseases.

💼 Professional Endeavors

Dr. Carannante has held several prestigious positions in the field of colorectal and oncological surgery. Since November 2021, he has been a consultant colorectal surgeon at the Campus Bio-Medico Polyclinic Foundation of Rome. In September 2023, he was appointed a professor of Oncological and Digestive Surgery at the Campus Bio-Medico University of Rome. He is also an active member of the Italian Society of Colorectal Surgery (SICCR) and the Italian Society of Surgical Oncology (SICO), where he serves on the young boards, and is part of the Lower GI Group at the American College of Surgeons (ACS).

🔬 Contributions and Research Focus

Dr. Carannante's research contributions are significant, particularly in the areas of colorectal surgery and minimally invasive surgical techniques. His work includes innovative studies on the outcomes of rectal cancer treatments and the feasibility of minimally invasive colectomy in fragile patients. He has also contributed to advancements in laparoscopic and abdominal wall surgery, and has been involved in multiple research projects at renowned institutions across Europe.

🏆 Accolades and Recognition

Dr. Carannante has received numerous awards for his contributions to surgery and research. Notably, he was awarded the "Ettore Ruggieri" Scholarship by the Italian Society of Surgery (SIC) in 2023 and the "Francesco Mazzeo" Award by the Italian Society of Pathology of the Digestive System (SIPAD) in 2024. Additionally, he received the "Best Oral Presentation" award at a national congress for his study on minimally invasive colectomy.

🌍 Impact and Influence

Dr. Carannante's influence extends beyond his immediate professional environment. He serves on the editorial boards of several prestigious journals, including the International Journal of Colorectal Disease and the World Journal of Surgical Oncology. His h-index of 15 and over 828 citations highlight the impact of his research on the global medical community. He is also a reviewer for numerous scientific publications, ensuring the quality and advancement of research in his field.

🏅 Legacy and Future Contributions

Dr. Carannante's legacy is marked by his dedication to advancing the field of colorectal and oncological surgery through both clinical practice and research. His ongoing roles in various surgical societies and academic institutions position him to continue making significant contributions to the medical field. His commitment to education, research, and clinical excellence ensures that his influence will be felt for years to come, inspiring future generations of surgeons and researchers.

 

Publications 📄


📄Evaluation of Short-Term Effects on Colorectal Surgery Elective Patients after Implementing a Patient Blood Management Program: A Multicenter Retrospective Analysis
Authors: Filippo Carannante, Gabriella Teresa Capolupo, Manuel Barberio, Amedeo Altamura, Valentina Miacci, Martina Zenobia Scopigno, Erika Circhetta, Gianluca Costa, Marco Caricato, Massimo Giuseppe Viola
Journal: [Special Issue: Challenges in Minimally Invasive Colorectal and Abdominal Wall Surgery], Year : 2024


📄Laparoscopic right hemicolectomy: a SICE (Società Italiana di Chirurgia Endoscopica e Nuove Tecnologie) network prospective study on the approach to right colon lymphadenectomy in Italy: is there a standard?—CoDIG 2 (ColonDx Italian Group)
Authors: Anania, G., Chiozza, M., Campagnaro, A., Zago, M., Zerbinati, A.
Journal: Surgical Endoscopy, Year : 2024


📄Effect of centre volume on pathological outcomes and postoperative complications after surgery for colorectal cancer: results of a multicentre national study
Authors: Rottoli, M., Spinelli, A., Pellino, G., Rausa, E., Celentano, V.
Journal: British Journal of Surgery, Year : 2024


📄Long-term patient-reported outcomes after anti-reflux surgery for gastroesophageal reflux disease and hiatal hernia repair: a single-center experience
Authors: Peltrini, R., Carannante, F., Giovine, G., Capolupo, G.T., Borzomati, D.
Journal: Minerva Surgery, Year : 2023


📄Surgeons’ practice and preferences for the anal fissure treatment: results from an international survey
Authors: Balla, A., Saraceno, F., Shalaby, M., Ziprin, P., Zizzo, M.
Journal: Updates in Surgery, Year : 2023